Sign In
Buy EHC
$103.17
+1.62 (+1.60%)
At Close: Jun 03, 2026
Encompass Health reports results for first quarter 2024
04:15pm, Wednesday, 24'th Apr 2024
Increases full-year guidance BIRMINGHAM, Ala. , April 24, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the Un
Watch These 5 Medical Stocks for Q1 Earnings: Beat or Miss?
12:41pm, Tuesday, 23'rd Apr 2024
Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is l
Insights Into Encompass Health (EHC) Q1: Wall Street Projections for Key Metrics
10:21am, Tuesday, 23'rd Apr 2024
Evaluate the expected performance of Encompass Health (EHC) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key me
Should You Buy Encompass Health (EHC) Ahead of Q1 Earnings?
02:36pm, Monday, 22'nd Apr 2024
Encompass Health's (EHC) Q1 results are likely to benefit on the back of growing patient volumes and commendable expansion initiatives.
Are Investors Undervaluing Encompass Health (EHC) Right Now?
10:46am, Tuesday, 16'th Apr 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Encompass Health announces date of 2024 first quarter earnings call
04:30pm, Wednesday, 10'th Apr 2024
BIRMINGHAM, Ala. , April 10, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its first quarter ended March 31, 2024, after the market closes Wednesd
Encompass Health (EHC) Plans a 50-Bed Facility to Serve Texas
02:41pm, Thursday, 04'th Apr 2024
Encompass Health (EHC) unveils plans to build an inpatient rehabilitation hospital in San Antonio to bring improved health outcomes and further fortify its presence in Texas.
Encompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy?
10:46am, Wednesday, 27'th Mar 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
10:51am, Monday, 18'th Mar 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Encompass Health (EHC) Up 42% in a Year: What Lies Ahead?
01:51pm, Friday, 15'th Mar 2024
Encompass Health (EHC) remains well-poised for growth on the back of sustained top-line growth, an expanding healthcare facility portfolio and robust cash-generating abilities.
An In-Depth Analysis of Encompass Health's (EHC) 2024 Outlook
12:16pm, Tuesday, 12'th Mar 2024
Growth in Medicare and Managed Care pricing, along with capacity additions of six de novos with 280 beds, will likely have an impact on Encompass Health's (EHC) 2024 bottom line.
Encompass Health (EHC), Piedmont to Build Loganville Facility
01:51pm, Monday, 11'th Mar 2024
Encompass Health (EHC) partners with Piedmont to construct a 40-bed inpatient rehabilitation hospital in Georgia to better serve the rehabilitative care needs of the state and solidify its footprint.
Here's Why Encompass Health (EHC) is a Strong Value Stock
10:46am, Monday, 11'th Mar 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Encompass Health to present at Barclays Global Healthcare Conference
07:45am, Tuesday, 05'th Mar 2024
BIRMINGHAM, Ala. , March 5, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held in Miami, Flo
Encompass Health (EHC) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Tuesday, 27'th Feb 2024
Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
